Yissum Research Development Company of the Hebrew University
Yissum Research Development Company is the technology transfer company of the Hebrew University of Jerusalem. Founded in 1964, it is the third tech transfer company in the world to be created, and seeks to convert research into commercial solutions.
Yissum has founded more than 170 start-up companies, over 100 of which are still active in 2020, registered over 10,750+ patents globally, and licensed over 1050+ technologies. Yissum’s business partners include Boston Scientific, Google, ICL, Intel, Johnson & Johnson, Merck, Microsoft, Novartis, GRAIL, and many more.
Yissum has signed collaboration agreements with Cornell, UCBerkeley, Caltech, Carnegie Mellon University, Children's Medical Center, Columbia University, Harvard University, Johns Hopkins University, MIT, Mayo Clinic, Michigan State University, NYU, Northwestern University, Rockefeller University, Stanford University among other renowned educational institutions.
History
Yissum was founded in 1964 to protect and market the Hebrew University’s intellectual property. Since its inception, Yissum has founded more than 170 start-up companies, over 100 of which are still active in 2020, registered over 10,750+ patents globally, and licensed over 1050+ technologies. Yissum’s business partners span the globe and include companies such as Boston Scientific, Google, ICL, Intel, Johnson & Johnson, Merck, Microsoft, Novartis, Teva GRAIL, and many more.Yissum has signed collaboration agreements with Cornell, UCBerkeley, Caltech, Carnegie Mellon University, Children's Medical Center, Columbia University, Harvard University, Johns Hopkins University, MIT, Mayo Clinic, Michigan State University, NYU, Northwestern University, Rockefeller University, Stanford University among other renowned educational institutions.
In Israel, technology transfer entities are organized as companies, unlike the United States. In the United States technology transfer operations only began after the Bayh–Dole Act in 1982. Yissum is a for-profit company which is fully owned by the Hebrew University which is a not-for-profit entity. This makes Yissum a non-typical entity.
Yissum founded Integra Holdings in 2012.
In 2014, QLight Nanotech, a subsidiary of Yissum partly owned by Merck, opened an R&D facility in Jerusalem for developing advanced LED lighting and displaypanels.
Yissum founded Agrinnovation in 2015.
Start-up companies
- QLight Nanotech - A subsidiary of Yissum, is a start up partly owned by Merck KGaA. In 2013, QLight opened a new facility in Jerusalem.
- MobilEye
- BriefCam
- HumanEyes
- OrCam
- Ex Libris Group
| BioCancell Ltd-Anchiano Therapeutics |
| Biosensor Applications Sweden |
| Futuragene |
| Collplant Ltd |
| En-Gibton Ltd |
| Galinova - Novagali |
| HumanEyes Technologies Ltd |
| Intec Pharmaceuticals |
| MobilEye VISION TECHNOLOGIES LTD |
| Nanoptics Ltd |
| PLR |
| Ravgalai Ltd |
| Syndromex Ltd |
| Tiltan Pharma |
| Treatec 21 INDUSTRIES LTD |
| Aferrix Ltd. |
| Bio Park |
| Tolarex/Enlivex |
| H2Q Water Industries Ltd |
| BriefCam Ltd. |
| Qlight Ltd. |
| CoolCite |
| HIL Applied Medical Ltd. |
| MacroBea |
| LipoMedix |
| Plant Array Ltd |
| LipoCure |
| Morflora LLC / Morflora Israel |
| Steam Coffee Culture LTD |
| Immune Pharmaceuticals Ltd. |
| Nanosys |
| Integra Holdings Ltd |
| Lyotropic Delivery Systems Ltd. |
| Avraham Pharmaceuticals Ltd. |
| Paulee Cleantec |
| Melodea Ltd |
| Raziel Therapeutics Ltd. |
| InnerEye Ltd. |
| Ayana Pharma |
| OrCam Ltd. |
| I-Class |
| Valentis Nanotech Ltd. |
| Pepticom |
| Bactusense Ltd |
| Lipogreen |
| Seevix Material Sciences |
| HepaRx Ltd. |
| OphRx Ltd |
| Neteera Technologies |
| Clairion |
| NanoAF |
| GuideIn Medical Ltd. |
| Voyager Medical Ltd. |
| BioNanoSim Ltd. |
| Agrinnovation G.P. Ltd. |
| Ex Libris Ltd |
| AquiNovo LTD. |
| Kalytera Therapeutics |
| NrgStorEdge |
| NewStem Ltd |
| SpliSense |
| GemmaCert Ltd - Sensory detection of active ingredient, composition and dosage levels in cannabis plants |
| Tissue Dynamics |
| ChickP |
| Tefuture LTD |
| Nectin Therpeutics LTD. |
| APIX Nutrition Ltd. |
| Smart Resilin Ltd. |
| Betalin Therapeutics Ltd. |
| Prorogo LTD |
| Compira Labs |
| Amenity Analytics |
| DAGlabs |
| QED-it Systems Ltd. |
| Biobetter Ltd |
| NeoProl Ltd. |
| Trieye Ltd |
| Zion Pharmaceutical Ltd |
| BioBlast Pharma Ltd. |
| Future Meat Technologies LTD. |
| CardioVia Ltd |
| Better Juice Ltd |
| SolCold Ltd. |
| Trendit |
| My Or |
| Kiralis |
| QuantLR |
| SkinApp |
| SavorEat |
| MEDPNC |
| Quanabis |
| Celluflux Ltd |
| 3Biotix AEON Bio Pharma |
| R&L Renew Senses |
| HighRAD |
| Pilpel Seeds Ltd. |
| REMODELESS CV LTD |
| BacoCure |
| Cognifiber |
| Amendis LTD |
| Catalife |
| VitaLunga |
| Sufresca |
Products brought to market by Yissum
- Exelon - A cholinesterase inhibitor, a type of medicine prescribed for people in the early or middle stages of Alzheimer's disease. Invented by Marta Weinstock-Rosin.
- Doxil - additional information can be found also at Doxorubicin - For the treatment of patients with ovarian cancer. Invented by Yechezkal Barenholz and Alberto Gabizon.
- PerioChip - For reduction of pocket depth in patients with chronic periodontitis. Invented by Michael Friedman, Michael Sela and Doron Steinberg
- Cherry tomatoes and long shelf life tomatoes - Invented by Haim Rabinowitch and Nachum Kedar.
- Hybrid peppers - Invented by Yonatan Elkind.
- LO2 Eye Drops - Invented by Shabtay Dikstein
- Cationorm - For relief to patients suffering from dry eye symptoms. Invented by Simon Benita.
- UV-Pearl Technology - Invented by David Avnir